{"id":79,"date":"2024-11-16T10:48:23","date_gmt":"2024-11-16T10:48:23","guid":{"rendered":"https:\/\/drhatemmasmoudi.com\/?page_id=79"},"modified":"2024-11-16T17:48:57","modified_gmt":"2024-11-16T17:48:57","slug":"publications","status":"publish","type":"page","link":"https:\/\/drhatemmasmoudi.com\/index.php\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbHeader\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bbgcid-a674551e-c023-4666-82b8-b7448e713885&Prime; max_width=\u00a0\u00bb1280px\u00a0\u00bb border_radii=\u00a0\u00bboff||6px|6px|\u00a0\u00bb box_shadow_style=\u00a0\u00bbpreset4&Prime; box_shadow_horizontal=\u00a0\u00bb-30vw\u00a0\u00bb box_shadow_vertical=\u00a0\u00bb0px\u00a0\u00bb box_shadow_color=\u00a0\u00bbgcid-a674551e-c023-4666-82b8-b7448e713885&Prime; global_colors_info=\u00a0\u00bb{%22gcid-a674551e-c023-4666-82b8-b7448e713885%22:%91%22background_color%22,%22box_shadow_color%22,%22background_color%22,%22box_shadow_color%22%93}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbPublications\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bb7ef89d6c-cf15-435d-b1b5-d651ef73bce4&Prime; title_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbWork Experience\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb1280px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbOuvrages\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bb483529f5-7c9a-487e-b7ac-5dd2c0f80ce9&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb1280px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.27.3&Prime; _module_preset=\u00a0\u00bb790b4879-4a2a-40df-9a46-f309ccd290ec\u00a0\u00bb hover_enabled=\u00a0\u00bb0&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb sticky_enabled=\u00a0\u00bb0&Prime; custom_padding=\u00a0\u00bb||0px|||\u00a0\u00bb]<\/p>\n<p><span>1\/ Analysis of the cellular origin of T15 idiotype.<\/span><br \/><span>P.A CAZENAVE, H. MASMOUDI, T. MOTA-SANTOS, A. COUTINHO.<\/span><br \/><span>In : Idiotypic networks in Biology and Medicine.<\/span><br \/><span>Elsevier Science Publishers, Amsterdam, 1990, 65 \u2013 68.<\/span><\/p>\n<p><span>2\/ Immunologie fondamentale et immunopathologie \u00e0 l\u2019usage des \u00e9tudiants en <\/span><span>M\u00e9decine, Biologie et Pharmacie \uf0b2.<\/span><br \/><span>Hatem MASMOUDI et Amel EL GAAIED BEN AMMAR.<\/span><br \/><span>Centre de Publications Universitaire de Tunis, Collection Sciences <\/span><span>M\u00e9dicales, D\u00e9cembre 2000.<\/span><br \/><span>Ouvrage de 272 pages et 21 chapitres (nous avons r\u00e9dig\u00e9 19 des 21 chapitres).<\/span><\/p>\n<p><span>3\/ Les pr\u00e9l\u00e8vements en Immunologie. H. MASMOUDI.<\/span><br \/><span>In : Les pr\u00e9l\u00e8vements en biologie clinique.<\/span><br \/><span>S. GARGOURI, A. BEN AMOR, N. BOUJAAFAR, A. HEDHILI, <\/span><span>H. MASMOUDI, A. OUESLATI, A. SLIM, M. A. MEMMI.<\/span><br \/><span>Unit\u00e9 des laboratoires de biologie m\u00e9dicale, Minist\u00e8re de la Sant\u00e9 Publique, <\/span><span>Novembre 2001, p 44 \u2013 47.<\/span><\/p>\n<p><span>4\/ Pr\u00e9sentation g\u00e9n\u00e9rale du syst\u00e8me immunitaire.<\/span><br \/><span>M. BEN AYED, S. HADDOUK, H. MASMOUDI.<\/span><br \/><span>In : Abr\u00e9g\u00e9 de physiologie \u00e0 l\u2019usage des acupuncteurs et des r\u00e9flexoth\u00e9rapeutes.<\/span><br \/><span>Sous la direction d\u2019Yves ROUXEVILLE. Springer. Paris, 2013.<\/span><\/p>\n<p><span>5\/ Immunit\u00e9 et r\u00e9infection par le nouveau coronavirus : entre mythe et r\u00e9alit\u00e9.<\/span><br \/><span>In : Covid-19 : La Tunisie abassourdie.<\/span><br \/><span>Ouvrage collectif sous la direction de Taoufik Habaieb, Leaders 2021<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbEducation\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb1280px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_heading title=\u00a0\u00bbArticles \u00a0\u00bb _builder_version=\u00a0\u00bb4.27.3&Prime; _module_preset=\u00a0\u00bb483529f5-7c9a-487e-b7ac-5dd2c0f80ce9&Prime; hover_enabled=\u00a0\u00bb0&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb sticky_enabled=\u00a0\u00bb0&Prime;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb1280px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.27.3&Prime; _module_preset=\u00a0\u00bb790b4879-4a2a-40df-9a46-f309ccd290ec\u00a0\u00bb hover_enabled=\u00a0\u00bb0&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb sticky_enabled=\u00a0\u00bb0&Prime;]<\/p>\n<p>1\/ LES FREQUENCES GENIQUES DES GROUPES SANGUINS ABO ET RHESUS DANS LA POPULATION TUNISIENNE.<br \/>H. MASMOUDI, A. ZAIEM.<br \/>La Tunisie M\u00e9dicale, Vol. 64, N\u00b0 6 \u2013 7, Juin \u2013 Juillet 1986, 586 \u2013 585.<\/p>\n<p>2\/ AUTO-ANTICORPS ANTI-IDIOTYPIQUES DES ANTICORPS ANTI-DNA DANS LE LUPUS ERYTHEMATEUX DISSEMINE.<br \/>H. MASMOUDI, S. MAKNI, J.F BACH.<br \/>La Tunisie M\u00e9dicale, Vol.67, N\u00b0 10, Octobre 1989, 617 \u2013 620.<\/p>\n<p>3\/ NEW ALLOTYPES OF THE MURINE GAMMA 1 IMMUNOGLOBULINS.<br \/>H. MASMOUDI, F. BONHOMME, P.A CAZENAVE.<br \/>Molecular Immunology, 1989, 26, 551 \u2013 555.<\/p>\n<p>4\/ DIVERGENCY IN THE SPECIFICITY OF THE INDUCTION AND MAINTENANCE OF NEONATAL SUPPRESSION (T. MOTA-SANTOS, H. MASMOUDI, D. VOEGTLE, A. FREITAS, A. COUTINHO, P.A CAZENAVE.<br \/>European Journal of Immunology. 1990, 20, 1717 \u2013 1721.<\/p>\n<p>5\/ ALL T15 ID-POSITIVE ANTIBODIES (BUT NOT THE MAJORITY OF VHT15 ANTIBODIES) ARE PRODUCED BY PERITONEAL CD5+ B<br \/>LYMPHOCYTES.<br \/>H. MASMOUDI, T. MOTA-SANTOS, F. HUETZ, A. COUTINHO, P.A CAZENAVE.<br \/>International Immunology, 1990, Vol.2, N\u00b06, 515 \u2013 520.<\/p>\n<p>6\/ ASTHME PROFESSIONNEL AU BOIS : A PROPOS D\u2019UN CAS.<br \/>D. REBAI, T. MAKKI, M. AYADI, F.M JAMOUSSI, H. MASMOUDI.<br \/>Maghreb Medical, Novembre 1993, N\u00b0273, 16 \u2013 18.<\/p>\n<p>7\/ HEPATITE VIRALE C CHEZ LES HEMODIALYSES CHRONIQUES DANS LE SUD TUNISIEN : PREVALENCE ET FACTEURS DE RISQUE.<br \/>J. HACHICHA, A. HAMMAMI, H. MASMOUDI, M. BEN HMIDA, M. KHARRAT, F. KAMMOUN, A. JARRAYA.<br \/>Annales de M\u00e9decine Interne. 1995, 146, N\u00b05, 295 \u2013 298.<\/p>\n<p>8\/ \uf0b2BARE LYMPHOCYTE SYNDROME\uf0b2 TYPE II. A PROPOS D\u2019UN CAS.<br \/>H. MASMOUDI, M.R BARBOUCHE, A. MAHFOUDH, T. KAMMOUN, R. BARDI, M. BEJAOUI, R. LAKHOUA, M. HACHICHA, K. AYED, K. DELLAGI, A. TRIKI.<br \/>Revue maghr\u00e9bine de p\u00e9diatrie. Volume VI, N\u00b02, 89 \u201392, Mars \u2013 Avril 1996,<\/p>\n<p>9\/ MYELOPATHIES LUPIQUES ET ANTICORPS ANTI-PHOSPHOLIPIDES : 2 CAS.<br \/>I. FEKI, M. BEN HMIDA, H. MASMOUDI, C. TRIKI, Z. BAHLOUL, J. HACHICHA, R. JLIDI, C. MHIRI.<br \/>Revue de Neurologie. Paris. 1997, 153 : 2, 138 \u2013 40.<\/p>\n<p>10\/ ERYTHROBLASTOPENIE CHRONIQUE ASSOCIEE A UNE GAMMAPATHIE MONOCLONALE ET A UN LUPUS : A PROPOS D\u2019UN CAS.<br \/>H. MASMOUDI, M. ELLOUMI, M. FRIKHA, S. MSEDDI, M. BOUAZIZ, T. SOUISSI.<br \/>Semaine des H\u00f4pitaux. F\u00e9vrier 1997, N\u00b0 5 \u2013 6, 159 \u2013 162.<\/p>\n<p>11\/ LE CONTROLE DE QUALITE DANS L\u2019IMMUNODOSAGE DES MARQUEURS TUMORAUX CIRCULANTS AFP, ACE ET CA15-3.<br \/>M. BEN AYED, Y. BEN HADJ HMIDA, M. KASSIS, J. DAMAK, H. MASMOUDI.<br \/>Biologie Clinique. Novembre 1998, N\u00b09, 27 \u2013 33.<\/p>\n<p>12\/ EPANCHEMENT PLEURAL PLASMOCYTAIRE REVELATEUR D\u2019UN MYELOME MULTIPLE.<br \/>M. ELLOUMI, M. FRIKHA, H. MASMOUDI, S. MSEDDI, M. BEN AYED, M. BOUAZIZ, F. MAKNI, T. SOUISSI.<br \/>Revue des maladies respiratoires. 2000, 17, 495 \u2013 497.<\/p>\n<p>13\/ PRESENCE ISOLEE DE L\u2019ANTICORPS ANTI-HBC : PREVALENCE ET INTERPRETATION A L\u2019AIDE DES RESULTATS DE RECHERCHE DE L\u2019ADNVIRAL ET DU DOSAGE DES ANTICORPS ANTI-HBS APRES VACCINATION.<br \/>M. BEN AYED, H. TRIKI, D. COINTE, H. KARRAY, M.A MASMOUDI, K. DELLAGI, L. GRANGEOT, A. HAMMAMI, H. MASMOUDI.<br \/>Annales de Biologie Clinique. Janvier-F\u00e9vrier 2001, vol. 59, n\u00b01, 53 \u2013 60.<\/p>\n<p>14\/ MENINGITE CARCINOMATEUSE REVELATRICE DE CANCER : ETUDE DE DEUX CAS.<br \/>S. SAMET, F. BELAHSEN, Ch. TRIKI, H. MASMOUDI, R. JLIDI, Ch. MHIRI.<br \/>La Tunisie M\u00e9dicale. Avril 2001, vol. 79, n\u00b004, 257 \u2013 260.<\/p>\n<p>15\/ LE CONTROLE DE QUALITE DANS LE DOSAGE DES MARQUEURS TUMORAUX : METHODOLOGIE, RESULTATS ET PROBLEMES POSES.<br \/>M. BEN AYED, Y. BEN HADJ HMIDA, M. KASSIS, J. DAMAK, H. MASMOUDI.<br \/>La Tunisie M\u00e9dicale. Juin-Juillet 2001, vol. 79, n\u00b0 6 \/ 7, 341 \u2013 347.<\/p>\n<p>16\/ SENSIBILITE, SPECIFICITE ET VALEUR PRONOSTIQUE DE L\u2019ACE DANS LE CANCER DU COLON-RECTUM : RESULTATS D\u2019UNE SERIE<br \/>TUNISIENNE ET REVUE DE LA LITTERATURE.<br \/>Y. BEN HADJ HMIDA, N. TAHRI, A. SELLAMI, N. YANGUI, R. JLIDI, M.I BEYROUTI, M.S KRICHEN, H. MASMOUDI.<br \/>La Tunisie M\u00e9dicale.Ao\u00fbt-Septembre 2001, vol. 79, n\u00b0 8 \/ 9, 434 \u2013 440.<\/p>\n<p>17\/ PEMPHIGUS IS NOT ASSOCIATED WITH ALLOTYPIC MARKERS OF IMMUNOGLOBULIN KAPPA.<br \/>M. ZITOUNI, P. MARTEL, G. RAUX, M. BEN AYED, D. GILBERT, P. JOLY, H. TURKI, A. ZAHAF, J. GARGOURI, M. MOKNI, A. BEN OSMAN, H.<br \/>MASMOUDI, S. MAKNI, F. TRON.<br \/>Genes and Immunity. 2002, n\u00b03, 50 \u201352.<\/p>\n<p>18\/ TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS IS ASSOCIATED WITH DESMOGLEIN 1 GENEPOLYMORPHISM.<br \/>M. BEN AYED, P. MARTEL, M. ZITOUNI, D. GILBERT, H. TURKI, M. MOKNI, A. BEN OSMAN, M.R KAMOUN, A. ZAHAF, S. MAKNI, H. MASMOUDI, F. TRON.<br \/>Genes and Immunity. 2002, n\u00b03, 378 \u2013 9.<\/p>\n<p>19\/ CICLOSPORINE A DANS LE TRAITEMENT DE L\u2019HEPATITE AUTO- IMMUNE DE L\u2019ENFANT : A PROPOS DE 1 CAS.<\/p>\n<p>N. BEN HALIMA, M. CHAABOUNI, A. KARRAY, A. KRICHEN, H. MASMOUDI, R. JLIDI, A. TRIKI.<br \/>La Tunisie M\u00e9dicale. 2002, vol. 80, n\u00b09, 565 \u2013 569.<\/p>\n<p>20\/ CRITERES DE CHOIX D\u2019UN AUTOMATE D\u2019IMMUNOANALYSE.<br \/>H. MASMOUDI.<br \/>Revue Tunisienne de Biologie Clinique. D\u00e9cembre 2002, n\u00b014, 34 \u2013 40.<\/p>\n<p>21\/ APPROCHE POUR L\u2019ETABLISSEMENT DES VALEURS DE REFERENCE (VARIATIONS NORMALES) DANS LA POPULATION TUNISIENNE DE 9 PROTEINES PLASMATIQUES EN SE BASANT SUR LE MATERIAU DE REFERENCE CRM470 DE L\u2019IFCC.<br \/>R. ZNAZEN, M. BEN AYED, J. GARGOURI, Y. BEL HADJ HMIDA, M. KASSIS, J. DAMAK, H. MASMOUDI.<br \/>La Tunisie m\u00e9dicale. Vol 81, n\u00b0 04, 2003 ; 264 \u2013 269.<\/p>\n<p>22\/ ANTI-DESMOGLEIN 1 ANTIBODIES IN TUNISIAN HEALTHY SUBJECTS: ARGUMENTS FOR THE ROLE OF ENVIRONMENTAL FACTORS IN OCCURENCE OF TUNISIAN PEMPHIGUS FOLIACEUS.<br \/>M. KALLEL-SELLAMI, M. BEN AYED, H. MOUQUET, L. DROUOT, M. ZITOUNI, M. MOKNI, M. CERRUTI, H. TURKI, B. FEZZA, I. MOKHTAR, A.<br \/>BEN OSMAN, A. ZAHAF, M.R KAMOUN, P. JOLY, H. MASMOUDI, S. MAKNI, F. TRON, D. GILBERT.<br \/>Clinical and experimentalimmunology. 2004 ; 137 : 195 \u2013 200.<\/p>\n<p>23\/ DOSAGE DES ANTICORPS ANTI-TRANSGLUTAMINASE DANS LE DIAGNOSTIC DE LA MALADIE C\u0152LIAQUE DE L\u2019ENFANT : RESULTATS<br \/>D\u2019UNE ETUDE PROSPECTIVE SUR CINQ ANS.<br \/>L. LAADHAR, N. BOUAZIZ, M. BEN AYED, M. CHAABOUNI, T. BOUDAWARA, M. HACHICHA, R. JLIDI, A. TRIKI, H. MASMOUDI.<br \/>Annales de Biologie Clinique. 2004 ; 62 : 431 \u2013 6.<\/p>\n<p>24\/ NON REPONSE AU VACCIN DE L\u2019HEPATITE B CHEZ LE PERSONNEL DE SANTE.<br \/>S.MAROUEN-JAMOUSSI, D. CHTOUROU, A. KAMMOUN, N. MAHFOUDH, H. MAKNI, H. KARRAY, H. MASMOUDI, A. HAMMAMI, M.L MASMOUDI.<br \/>La Tunisie M\u00e9dicale, Juillet 2004 : 82 (7) : 674 \u2013 8.<\/p>\n<p>25\/GAMMAPATHIES MONOCLONALES EN TUNISIE : ANALYSE EPIDEMIOLOGIQUE, IMMUNOCHIMIQUE ET ETIOLOGIQUE D\u2019UNE<br \/>SERIE DE 288 CAS.<br \/>S. MSEDDI-HDIJI, S. HADDOUK, M. BEN AYED, N. TAHRI, M. ELLOUMI, S. BAKLOUTI, J. HACHICHA, M.S KRICHEN, Z. BAHLOUL, H. MASMOUDI.<br \/>PathologieBiologie, 2005 ; 53 : 19 \u2013 25.<\/p>\n<p>26\/ CLINICAL SIGNIFICANCE OF ANTI-NUCLEOSOME ANTIBODIES IN TUNISIAN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS.<br \/>S. HADDOUK, M. BEN AYED, S. BAKLOUTI, J. HACHICHA, Z. BAHLOUL, H. MASMOUDI.<br \/>ClinicalRheumatology, 2005 ; 24 : 219 \u2013 222.<\/p>\n<p>27\/AUTO-ANTICORPS DANS LE LUPUS ERYTHEMATEUX SYSTEMIQUE : PROFIL ET CORRELATIONS CLINIQUES.<br \/>S. HADDOUK, M. BEN AYED, S. BAKLOUTI, J. HACHICHA, Z. BAHLOUL, H. MASMOUDI.<br \/>Pathologie Biologie, 2005 ; 53 : 311 \u2013 317.<\/p>\n<p>28\/ GENETIC FACTORS IN PEMPHIGUS.<br \/>F. TRON, D. GILBERT, H. MOUQUET, P. JOLY, L. DROUOT, S. MAKNIH. MASMOUDI, D. CHARRON, M. ZITOUNI, P. LOISEAU, M. BEN AYED.<br \/>Journal of autoimmunity, 2005 ; 24 : 319 \u2013 328.<\/p>\n<p>29\/ PEMPHIGUS ERYTHEMATEUX TUNISIEN ASSOCIE A UN PSORIASIS CHEZ DEUX S\u0152URS.<br \/>A. MASMOUDI, H. HADJ TAIEB, M. BEN AYED, O. ABIDA, H. MAKNI, H. TURKI, H. MASMOUDI, A. ZAHAF.<br \/>AnnalesDermatoVenereol, 2006; 133: 181 \u2013 7.<\/p>\n<p>30\/ IMMUNOGENETICS OF PEMPHIGUS AN UPDATE. F. TRON, D. GILBERT, P. JOLY, H. MOUQUET, L. DROUOT,<br \/>M. BEN AYED, M. SELLAMI, H. MASMOUDI, S. MAKNI.<br \/>Autoimmunity, Novembre 2006; 39 (7): 531 \u2013 539.<\/p>\n<p>31\/ PN22 R620 W POLYMORPHISM AND PEMPHIGUS.<br \/>K. MEJRI, M. KALLEL-SALLEMI, E. PETIT-TEIXEIRA, O. ABIDA, M. HAMDI, M. ZITOUNI, H. TURKI, F. TRON, D. GILBERT, H. MASMOUDI, F. CORNELIS, S. MAKNI.<br \/>British Journal of Dermatology, Nov 2007 ; 157 (5) : 1068 \u2013 9.<\/p>\n<p>32\/ MARQUEURS DE RISQUE DU DIABETE DE TYPE 1 CHEZ LES APPARENTES AU PREMIER DEGRE DES DIABETIQUES TUNISIENS.<br \/>L. LAADHAR, A. GASSARA, N. MAHFOUDH, Y. BEN HADJ HMIDA, T. KAMOUN, M. BEN AYED, N. REKIK, A. MAHFOUDH, A. REBAI, H. MAKNI, M. ABID, M. HACHICHA, H. MASMOUDI.<br \/>Annales d\u2019Endocrinologie, Juin 2007, 68 (2 \u2013 3) : 181 \u2013 185.<\/p>\n<p>33\/ DERMATOSES BULLEUSES AUTO-IMMUNES MULTIPLES DANS UNE MEME FAMILLE.<br \/>A. MASMOUDI, H. CHIKHROUHOU, F. FRIQUI, O. ABIDA, M. BEN AYED, N. LEHYANI, M. AMOURI, H. MASMOUDI, H. MAKNI, A. ZAHAF, H. TURKI.<br \/>Annales de Dermatologie et de V\u00e9n\u00e9reologie, Juin-Juillet 2007 ; 134(6- 7) : 572 -3.<\/p>\n<p>34\/ ANTI-DESMOGLEIN-1 ANTIBODIES ARE PREVALENT IN TUNISIAN PATIENTS WITH HYDATIDOSIS AND LEISHMANIASIS.<br \/>M. KALLEL-SELLAMI, M. ZITOUNI, W. TOMBARI, M. BEN AYED, O. ABIDA, L. LAADHAR, M. MOKNI, B. FEZAA, H. TURKI, I. MOKHTAR, A.<br \/>BEN OSMAN, M.R KAMOUN, P. JOLY, F. TRON, D. GILBERT, H. MASMOUDI, S. MAKNI.<br \/>British Journal of Dermatology, Mars 2007 ; 156 (3) : 591 \u2013 3.<\/p>\n<p>35\/ PROTECTIVE EFFECT OF 17\uf062-ESTRADIOL ON OXIDATIVE STRESSE AND LIVER DYSFUNCTION IN AGED MALE RATS.<br \/>K. HAMDEN, S. CARREAU, F. ELLOUZ, H. MASMOUDI, A. EL FEKI.<br \/>J. Physiol. Biochem., 2007 ; 63 (3) : 195 \u2013 202.<\/p>\n<p>36\/ TUNISIAN PEMPHIGUS FOLIACEUS WITH ANTI-DESMOGLEIN3 ANTIBODY.<br \/>A. MASMOUDI, S. BRICAULT, H. CHIKHROUHOU, A. ZAHAF, H. TURKI, O. ABIDA, M. BEN AYED, H. MASMOUDI, D. GILBERT, F. TRON, P. JOLY.<br \/>Annales de Dermatologie V\u00e9n\u00e9rologie, Janvier 2008 ; 135 (1) : 69 \u2013 70.<\/p>\n<p>37\/ PROTECTIVE EFFECTS OF PEGANUMHARMALA EXTRACTS ON THIOUREA-INDUCED DISEASES IN ADULT MALE RAT.<br \/>Kh. HAMDEN, H. MASMOUDI, F. ELLOUZ, A. ELFEKI, S. CARREAU.<br \/>J. Environ. Biol., 2008 ; 29 (1), 73 \u2013 77.<\/p>\n<p>38\/ COMBINED VITAMINS (C AND E) AND INSULIN IMPROVE OXIDATIVE STRESS AND PANCREATIC AND HEPATIC INJURY IN<br \/>ALLOXAN DIABETIC RATS.<\/p>\n<p>Kh. HAMDEN, M.A. BOUJBIHA, H. MASMOUDI, F. ELLOUZ, F. MAKNI- AYADI, K. JAMOUSSI, A. ELFEKI.<\/p>\n<p>Biomedicine&amp;Pharmacotherapy, 2008 ; 1 \u2013 5.<\/p>\n<p>39\/ ASSOCIATION DIABETE DE TYPE 1 ET MALADIE COELIAQUE CHEZ L\u2019ENFANT.<br \/>H. ALOULOU, T. KAMMOUN, M. BEN AYED, H. MASMOUDI, M. HACHICHA.<br \/>Journal de P\u00e9diatrie et de pu\u00e9riculture, 2008 ; 21 : 37 \u2013 43.<\/p>\n<p>40\/ VASCULARITE A ANTICORPS ANTICYTOPLASME DES POLYNUCLEAIRES NEUTROPHILES INDUITE PAR LE BENZYLTHIOURACILE : ETUDE DE TROIS OBSERVATIONSET REVUE DE LA LITTERATURE.<br \/>M. FRIGUI, M. KECHAOU, S. HADDOUK, A. MASMOUDI, N. KADDOUR, H. MASMOUDI, H. TURKI, Z. BAHLOUL.<br \/>Annalesd\u2019Endocrinologie, Septembre 2008 ; 69 : 517 \u2013 522.<\/p>\n<p>41\/ POSITIVE EFFECTS OF GREEN TEA ON HEPATIC DYSFUNCTION, LIPID PEROXIDATION AND ANTIOXIDANT DEFENCE DEPLETION<br \/>INDUCED BY CADMIUM.<br \/>Kh. HAMDEN, S. CARREAU, F. AYADI-MAKNI, H. MASMOUDI, A. EL FEKI.<br \/>Biol Res, 2008 ; 41 : 331 \u2013 339.<\/p>\n<p>42\/ LES AUTO-ANTICORPS PANCREATIQUES CHEZ LES ENFANTS DIABETIQUES DE PRIMO-DECOUVERTE DE TYPE 1 EN TUNISIE.<br \/>R. FAKHFAKH, S. HADDOUK, Y. BEN HADJ HMIDA, T. KAMOUN, M. BEN AYED, M. HACHICHA, H. MASMOUDI.<br \/>Pathologie Biologie, 2008 ; 56 (3) : 130 \u2013 132.<\/p>\n<p>43\/ SFP-P052 \u2013 P\u00c9DIATRIE G\u00c9N\u00c9RALE ET SOCIALE \u2013 PROFIL \u00c9PID\u00c9MIOLOGIQUE DU DIAB\u00c8TE DE TYPE 1 \u00c9TUDE PROSPECTIVE DE<br \/>184 CAS.<br \/>T. KAMOUN, A. BEN THABET, H. ALOULOU, Y. BEN HADJ HMIDA, M. BEN AYED, H. MASMOUDI, M. HACHICHA.<br \/>Archives de P\u00e9diatrie, Juin 2008 ; volume 15, Issue 5 : 959 \u2013 960.<\/p>\n<p>44\/THERAPEUTIC EFFECT OF PHYTOECDYSTEROIDS RICH EXTRACT FROM AJUGA IVA ON ALLOXAN INDUCED DIABETIC RATS LIVER,<br \/>KIDNEY AND PANCREAS.<br \/>Kh. HAMDEN, F. AYADI, K. JAMOUSSI, H. MASMOUDI, A. EL FEKI.<br \/>Biofactors, 2008 ; 33(3) : 165 \u2013 75.<\/p>\n<p>45\/ COMBINED VITAMINS (C AND E) AND INSULIN IMPROVE OXIDATIVE STRESS AND PANCREATIC AND HEPATIC INJURY IN5 ALLOXAN DIABETIC RATS.<br \/>Kh. HAMDEN, M.A BOUJBIHA, H. MASMOUDI, F. AYADI-MAKNI, K. JAMOUSSI, A. EL FEKI.<br \/>Biomedicine &amp; Pharmacotherapy, 2009 ; 63 : 95 \u2013 99.<\/p>\n<p>46\/ CLINICAL AND DIAGNOSTIC VALUE OF RIBOSOMAL P AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS.<br \/>S. HADDOUK, S. MARZOUK, M. JALLOULI, H. FOURATI, M. FRIGUI, Y. BEN HAJ HMIDA, F. KOUBAA, W. SELLAMI, S. BAKLOUTI, J. HACHICHA, Z. BAHLOUL, H. MASMOUDI.<br \/>Rheumatology, 2009 ; 48 : 953 \u2013 957.<\/p>\n<p>47\/ ANTI-DESMOGLEIN 1 ANTIBODIES IN HEALTHY SUBJECTS IN ENDEMIC AND NON-ENDEMIC AREAS FROM TUNISIA.<br \/>O. ABIDA, M. KALLEL-SALLEMI, P. JOLY, M. BEN AYED, M. ZITOUNI, A. MASMOUDI, M. MOKNI, B. FEZAA, A. BEN OSMAN, MR. KAMOUN, D.<br \/>GILBERT, H. TURKI, F. TRON, H. MASMOUDI , S. MAKNI.<br \/>Journal of the European Academy of Dermatology and Venereology, 2009 ; 23 : 1073 \u2013 1078.<\/p>\n<p>48\/ TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS IS ASSOCIATED WITH HLA-DR3 GENE: ANTI-DESMOGLEIN 1 ANTIBODY POSITIVE HEALTHY SUBJECTS BEAR PROTECTIVE ALLELES.<br \/>O. ABIDA, M. ZITOUNI, M. KALLEL-SALLEMI, N. MAHFOUDH, A. KAMOUN, M. BEN AYED, A. MASMOUDI, M. MOKNI, B. FEZAA, A. BEN<br \/>OSMAN, MR. KAMOUN, H. TURKI, H. MAKNI, D. GILBERT, P. JOLY, F. TRON, S. MAKNI, , H. MASMOUDI.<br \/>British Journal of Dermatology, 2009 ; 161(3) : 522 \u2013 7.<\/p>\n<p>49\/ THE FAMILIAL FEATURE OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS<br \/>O. ABIDA , A. MASMOUDI, A. REBA\u00cf, M. BEN AYED, N. MAHFOUDH, M. KALLEL-SELLAMI, S. MAKNI, P. JOLY, D. GILBERT, H. MAKNI, F. TRON, H. MASMOUDI,H. TURKI.<br \/>British Journal of Dermatology, 2009; 161(4): 951 \u2013 3.<\/p>\n<p>50\/ Inhibitory effect of Estrogens, Phytoestrogens and Caloric Restriction on\u00a0 Oxidative Stress and Hepato-toxicity in Aged Rats.<br \/>Kh. HAMDEN, S. CARREAU, F. AYADI, H. MASMOUDI, A. ELFEKI.<br \/>Biomedical and environmental sciences, 2009; 22(5): 381 \u2013 7.<\/p>\n<p>51\/ TRAF1\/C5 polymorphism is not associated with pemphigus.<br \/>K. MEJRI, H. MBAREK, M. KALLEL-SELLAMI, E. PETIT-TEIXEIRA, Y. ZERZERI, O. ABIDA, M. ZITOUNI, M. BEN AYED, M. MOKNI, B. FEZZA, H.<br \/>TURKI, F. TRON, D. GILBERT, H. MASMOUDI, B. PRUM, F. CORNELIS, S. MAKNI.<br \/>British Journal of Dermatology, Juin 2009 ; 160 (6) : 1348 \u2013 50.<\/p>\n<p>52\/ MALADIE D\u2019ADDISON AU COURS DE LA POLYENDOCRINOPATHIE AUTO-IMMUNE TYPE II : ASPECTS \u00c9PID\u00c9MIOLOGIQUES, CLINIQUES ET IMMUNOLOGIQUES.<br \/>F. MNIF, S. BEN SALAH, H. FOURATI, N. REKIK, N. CHARFI, H. MASMOUDI, M. ABID.<br \/>Diabetes &amp; Metabolism, Mars 2009 ; 35 suppl\u00e9ment1, P. A44.<\/p>\n<p>53\/ LIPID PEROXIDATION AND ANTI-OXIDANT SYSTEM IN THE TUMOR AND IN THE BLOOD OF PATIENTS WITH NASOPHARYNGEAL CARCINOMA.<br \/>B. GARGOURI, S. LASSOUED, W. AYADI, H. KARRAY, H. MASMOUDI, N. MOKNI, H. ATTIA, AE EL FEKI.<br \/>Biol Trace Elem Research, Dec 2009 ; 132 (1-3) : 27 \u2013 34.<\/p>\n<p>54\/ ENHANCED REACTIVITY TO MALONDIALDEHYDE-MODIFIED PROTEINS BY SYSTEMIC LUPUS ERYTHEMATOSUS AUTOANTIBODIES.<br \/>R. BEN MANSOUR, S. LASSOUED, A. ELGAIED, S. HADDOUK, S. MARZOUK, Z. BAHLOUL, H. MASMOUDI, H. ATTIA, MS AIFA, F. FAKHFAKH.<br \/>Scand J. Rheumatol, Mai 2010 ; 39(3) : 247-53.<\/p>\n<p>55\/ VALEUR DIAGNOSTIQUE ET SIGNIFICATION CLINIQUE DES MARQUEURS SEROLOGIQUES CHEZ LES PATIENTS TUNISIENS ATTEINTS DE MALADIES INFLAMMATOIRES DE L\u2019INTESTIN.<br \/>D. BOUZID, S. HADDOUK, A. AMOURI, Y. BEN HAJ HMIDA, S. BOUKTHIR, M. BEN AYED, N. TAHRI, H. MASMOUDI.<br \/>Annales de Biologie Clinique, Septembre-Octobre 2010 ; 68(5) : 577 \u2013 83.<\/p>\n<p>56\/ A COMPARATIVE STUDY OF THE OXIDATIVE PROFILE IN GRAVES\u2019DISEASE, HASHIMOTO\u2019S THYROIDITIS, AND PAPILLARY THYROID CANCER.<br \/>S. LASSOUED, M. MSEDDI, F. MNIF, M. ABID, F. GUERMAZI, H. MASMOUDI, A. EL FEKI, H. ATTIA.<br \/>Biol Trace ElemRes. D\u00e9cembre 2010 ; 138 (1-3) : 107 \u2013 15.<\/p>\n<p>57\/ Systemic sclerosis in a patient with pityriasisrubra pilaris.<br \/>F. FRIKHA, M. FRIGUI, H. MASMOUDI, H. TURKI, Z. BAHLOUL.<br \/>Pan African Medical Journal, Ao\u00fbt 2010 ; volume 6, Issue 6.<\/p>\n<p>58\/ Immunomodulatory, beta-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes.<br \/>K. HAMDEN, H. MASMOUDI, S. CARREAU, A. ELFEKI.<br \/>Immunopharmacol Immunotoxicol, Septembre 2010 ; 32(3) : 437-45.<\/p>\n<p>59\/ Dermatomyosites et polymyosites du sud tunisien : \u00e9tude de 67 cas.<br \/>N. KADDOUR, M. FRIGUI, S. MARZOUK, S. HADDOUK, M. MSEDDI, M. BEN AYED, H. MASMOUDI, H. TURKI, T. BOUDAOUARA, C. MHIRI, Z. BAHLOUL.<br \/>Revue Tunisienne de la Sant\u00e9 Militaire, D\u00e9cembre 2010 : 12 : 236 \u2013 42.<\/p>\n<p>60\/ ANTI-NUCLEOSOME ANTIBODIES MAY PREDICT LUPUS NEPHRITIS AND SEVERITY OF DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS.<br \/>S. HADDOUK, H. HACHICHA, S. MARZOUK, H. FOURATI, M. BEN HMIDA, S. BAKLOUTI, J. H ACHICHA, Z. BAHLOUL, H. MASMOUDI.<br \/>Indian Journal of Rheumatology, D\u00e9cembre 2010, volume 5, n\u00b04 ; pp. 165 \u2013 170.<\/p>\n<p>61\/ LA SCL\u00c9ROMYOSITE : \u00c0 PROPOS DE 8 OBSERVATIONS.<br \/>M. SNOUSSI, F. FRIKHA, M. FRIGUI, N. KADDOUR, F. MAAZOUN, R. BEN SALAH, F. NJAH, R. ALLALA, S. MARZOUK, M. JALLOULI, H. MASMOUDI, Z. BAHLOUL.<br \/>La revue de M\u00e9decine Interne, 2010 ; S404 \u2013 S501.<\/p>\n<p>62\/ HLA-DRB1\/DQB1 susceptibility for autoimmune polyglandular syndrome type II and III in south of Tunisia.<br \/>H. FOURATI, N. MAHFOUDH, O. ABIDA, A. KAMMOUN, F. MNIF, S. HADDOUK, M. BEN AYED, Y. BEN HADJ HMIDA, N. REKIK, M. ABID, H.<br \/>MAKNI, H. MASMOUDI.<br \/>Ann Endocrinol (Paris). 2011 Jun ; 72(3) : 232-8.<\/p>\n<p>63\/SPECTRUM OF AUTOANTIBODIES OTHER THAN ANTI-DESMOGLEIN IN PEMPHIGUS PATIENTS.<br \/>K. MEJRI, O. ABIDA, M. KALLEL-SELLAMI, S. HADDOUK, L. LAADHAR, I. ZARRAA, M. BEN AYED, M. ZITOUNI, M. MOKNI, H. LAHMAR, B. FEZAA, H. TURKI, F. TRON, H. MASMOUDI, S. MAKNI.<br \/>J. EurAcadDermatolVenereol, 2011 Jul ; 25(7) : 774-81.<\/p>\n<p>64\/ SYSTEMIC LUPUS ERYTHEMATOSUS-MYOSITIS OVERLAP SYNDROME: REPORT OF 6 CASES.<br \/>F. MAAZOUN, F. FRIKHA, M. SNOUSSI, N. KADDOUR, H. MASMOUDI, Z. BAHLOUL.<br \/>Clinics and Practice. 2011 ; volume 1 : e89.<\/p>\n<p>65\/ CONTRIBUTION OF IMMUNOFLUORESCENCE TO IDENTIFICATION AND CHARACTERIZATION OF ANTINEUTROPHIL CYTOPLASMIC<br \/>ANTIBODIES IN INFLAMMATORY BOWEL DISEASE.<br \/>D. BOUZID, S. HADDOUK, A. AMOURI, Y. BEN HADJ HMIDA, N. TAHRI, H. MASMOUDI.<br \/>Indian Journal of Gastroenterology. 2011 Sep ; 30 (5) : 229 \u2013 32.<\/p>\n<p>66\/ THE CREM GENE IS INVOLVED IN GENETIC PREDISPOSITION TO INFLAMMATORY BOWEL DISEASE IN THE TUNISIAN POPULATION.<br \/>D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, S. HADDOUK, M. BEN AYED, N. TAHRI, C. PENHA-GON\u00c7ALVES, H. MASMOUDI.<br \/>Human Immunology, December 2011 ; 72(12) : 1204 \u2013 9.<\/p>\n<p>67\/ LA VACCINATION ANTI-H\u00c9PATITE B AUX \u00c9TABLISSEMENTS PUBLICS DE SANT\u00c9 DE SFAX (TUNISIE).<br \/>I. GARGOURI, K. JMAL-HAMMAMI, A. SOBASZEK, H. MASMOUDI, H. KARRAY, A. HAMMAMI, P. FRIMAT, M.L MASMOUDI.<br \/>Archives des maladies professionnelles et de l\u2019environnement. 2011 ; 72 : 36 \u2013 43.<\/p>\n<p>68\/ CLINICAL IMPLICATIONS AND PROGNOSTIC SIGNIFICANCE OF THROMBOCYTOPENIA IN TUNISIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.<br \/>M. JALLOULI, M. FRIGUI, S. MARZOUK, M. SNOUSSI, M. KECHAOU, N. KADDOUR, H. MASMOUDI, M. ELLOUMI, Z. BAHLOUL.<br \/>Lupus, 2012 ; 21(6) : 682 \u2013 7.<\/p>\n<p>69\/ NON-HLA AUTOIMMUNITY GENETIC FACTORS CONTRIBUTING TO AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE II IN TUNISIAN<br \/>PATIENTS.<br \/>H. FOURATI, D. BOUZID, O. ABIDA, N. KHARRAT, F. MNIF, S. HADDOUK, C. FESEL, J. COSTA, M. BEN AYED, M. ABID, A. REBAI, C. PENHA-<br \/>GONCALVES, H. MASMOUDI.<\/p>\n<p>Human Immunology, 2012 ; 73 : 740 \u2013 746.<\/p>\n<p>70\/ ASSOCIATION OF THE RAVER2 GENE WITH INCREASED SUSCEPTIBILITY FOR ULCERATIVE COLITIS.<br \/>D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, S. HADDOUK, M. BEN AYED, N. TAHRI, C. PENHA-GONCALVES, H. MASMOUDI.<br \/>Hum Immunol, 2012 ; 73(7) : 732 \u2013 5.<\/p>\n<p>71\/ PREVALENCE ET VALEUR DIAGNOSTIQUE DES ANTI-NUCLEAIRESDE SPECIFICITE ANTIGENIQUE INDETERMINEE : ETUDE RETROSPECTIVE A PROPOS D\u2019UNE SERIE DE 90 PATIENTS.<\/p>\n<p>S. FEKI, F. FRIKHA, Y. BEN HADJ HMIDA, S. ABED, M. BEN AYED, H. TURKI, J. HACHICHA, S. BAKLOUTI, Z. BAHLOUL, H. MASMOUDI.<br \/>La Revue de M\u00e9decine Interne, 2012, volume 33, Issue 9, P 475 \u2013 486.<\/p>\n<p>72\/ REPLICATION OF IDENTIFIED INFLAMMATORY BOWEL DISEASES GENETIC ASSOCIATIONS: A CASE \u2013CONTROL STUDY IN THE TUNISIAN POPULATION.<br \/>D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, N. TAHRI, C. PENHA-GON\u00c7ALVES, H. MASMOUDI.<br \/>Journal of Clinical &amp; Cellular Immunology, 2012, doi.org\/10.4372\/2155-9899. S10-001.<\/p>\n<p>73\/ PREGNANCY IN DERMATOMYOSITIS AND POLYMYOSITIS.<br \/>N. KADDOUR, M. SNOUSSI, S. MARZOUK, F. FRIKHA, M. JALLOULI, M. FRIGUI, H. MASMOUDI, M. GUERMAZI, Z. BAHLOUL.<br \/>La TunisieM\u00e9dicale, 2012 ; 90(8) : 606-12.<\/p>\n<p>74\/ INFLAMMATORY BOWEL DISEASE : SUSCEPTIBILITY AND DISEASE HETEROGENEITY REVEALED BY HUMAN LEUKOCYTE ANTIGEN GENOTYPING.<br \/>D. BOUZID, A. KAMMOUN, A. AMOURI, N. MAHFOUDH, S. HADDOUK, N. TAHRI, H. MAKNI, H. MASMOUDI.<br \/>Genetic Testing and Molecular Biomarkers, 2012; 16(6): 482 \u2013 7<\/p>\n<p>75\/ CATALASE AND LIPID PEROXIDATION VALUES IN SERUM OF TUNISIAN PATIENTS WITH PEMPHIGUS VULGARIS AND FOLIACEUS.<br \/>O. ABIDA, R. BEN MANSOUR, B. GARGOURI, M. BEN AYED, A. MASMOUDI, H. TURKI, H. MASMOUDI, S. LASSOUED.<br \/>Biological Trace Element Research, Dec 2012 ; 150 (1 \u2013 3) : 74 \u2013 80.<\/p>\n<p>76\/ LE SYNDROME DES ANTISYNTHETASES : A PROPOS DE QUATRE OBSERVATIONS ET REVUE DE LA LITTERATURE.<br \/>F. FRIKHA, N. SAIDI, M. SNOUSSI, R. BEN SALAH, M. BEN AYED, E. DAOUD, Y. HENTATI, S. MAKNI, Z. MNIF, T. BOUDAWARA, H. MASMOUDI, Z. BAHLOUL.<br \/>Revue de Pneumologie clinique, 2012, Dec ; 68 (6) : 351 \u2013 60.<\/p>\n<p>77\/ GENETIC FACTORS CONTRIBUTING TO SYSTEMIC LUPUS ERYTHEMATOSUS IN TUNISIAN PATIENTS.<br \/>H. FOURATI, D. BOUZID, O. ABIDA, N. KHARRAT, S. MARZOUK, S. HADDOUK, C. FESEL, J. COSTA, M. BEN AYED, Z. BAHLOUL, C. PENHA-<br \/>CONCALVES, A. REBAI, H. MASMOUDI.<\/p>\n<p>Journal of Clinical and Cellular Immunology, 2012 ; 3 : 4.<\/p>\n<p>78\/ POLYMORPHISMS OF HLA MICROSATELLITE MARKER IN TUNISIAN PEMPHIGUS FOLIACEUS.<\/p>\n<p>O. ABIDA, N. MAHFOUDH, A. KAMMOUN, L. GADDOUR, F. HAKIM, A. TOUMI, A. MASMOUDI, M. BEN AYED, H. TURKI, H. MASMOUDI, H. MAKNI.<br \/>Human Immunology 2013 Jan ; 74(1) : 104-9.<\/p>\n<p>79\/ BIOMARKERS OF OXIDATIVE STRESS IN EPIDERMIS OF TUNISIAN PEMPHIGUS FOLIACEUS PATIENTS.<br \/>O. ABIDA, B. GARGOURI, R. BEN MANSOUR, M. MSEDDI-DJEMAL, A. MASMOUDI, M. BEN AYED, M. ABDELMOULA, H. TURKI, S. LASSOUED,<br \/>H. MASMOUDI.<br \/>Journal of the European Academy of Dermatology and Venereology, Mars 2013 ;27 (3) : e 271 \u2013 5.<\/p>\n<p>80\/ ASSOCIATION OF ZAP70 AND PTPN6, BUT NOT BANK1 OR CLEC2D,WITH INFLAMMATORY BOWEL DISEASE IN THE TUNISIAN POPULATION.<br \/>D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, S. HADDOUK, M. BEN AYED, N. TAHRI, C. PENHA GONCALVES, H. MASMOUDI.<br \/>Genetic Testing and Molecular Biomarkers. 2013 Apr ; 17(4) : 321-6.<\/p>\n<p>81\/ CYTOKINE GENE POLYMORPHISMS IN TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS: A POSSIBLE ROLE OF IL-4 VARIANTS.<br \/>A. TOUMI, O. ABIDA, M. BEN AYED, A. MASMOUDI, H. TURKI, H. MASMOUDI.<br \/>Human Immunology, 2013 May ; 74(5) : 658-65.<\/p>\n<p>82\/ AUTOIMMUNE REACTIVITY AGAINST PRECURSOR FORM OF DESMOGLEIN 1 IN HEALTHY TUNISIANS IN THE AREA OF ENDEMIC<br \/>PEMPHIGUS FOLIACEUS.<br \/>A. TOUMI, MA. SALEH, J. YAMAGAMI, O. ABIDA, M. KALLEL, A. MASMOUDI, S. MAKNI, H. TURKI, T. HACHIYA, K. KURODA, JR. STANLEY, H. MASMOUDI, M. AMAGAI.<br \/>Journal of Dermatological Science, 2013 Apr ; 70(1) : 19-25.<\/p>\n<p>83\/ SECRETED RECOMBINANT P53 PROTEIN FROM PICHIA PASTORIS IS A USEFUL ANTIGEN FOR DETECTION OF SERUM P53: AUTOANTIBODY IN PATIENTS WITH ADVANCED COLORECTAL ADENOCARCINOMA.<br \/>S. ABDELMOULA-SOUISSI, N. ZOUARI, I. MILADI-ABDENADHER, O. YAICH-KOLSI, I. AYADI-MASMOUDI, A. KHABIR, H. MASMOUDI, M. FRIKHA, R. MOKDAD-GARGOURI.<br \/>Molecular Biology Reports, 2013 May;40(5):3865-72.<\/p>\n<p>84\/ OXIDATIVE STRESS MARKERS IN INTESTINAL MUCOSA OF TUNISIAN INFLAMMATORY BOWEL DISEASES PATIENTS.<\/p>\n<p>D. BOUZID, B. GARGOURI, RB. MANSOUR, A. AMOURI, N. TAHRI, S. LASSOUED, H. MASMOUDI.<br \/>Saudi Journal of Gastroenterology, 2013 May-Jun ; 19 (3) : 131-5.<\/p>\n<p>85\/ ASSOCIATION STUDY OF MICA-TM POLYMORPHISM WITH INFLAMMATORY BOWEL DISEASE IN SOUTH TUNISIAN POPULATION.<br \/>A. KAMOUN, D. BOUZID, N. MAHFOUDH, A. AMOURI, L. GADDOUR, F. HAKIM, N. TAHRI, H. MASMOUDI, H. MAKNI.<br \/>Genetic Testing and Molecular Biomarkers, 2013 Aug; 17 (8) : 615-9.<\/p>\n<p>86\/ POLYMORPHISMS IN THE IL2RA AND IL2RB GENES IN INFLAMMATORY BOWEL DISEASE RISK.<br \/>D. BOUZID, A. AMOURI, H. FOURATI, I. MARQUES, O. ABIDA, N. TAHRI, CP. GONCALVES, H. MASMOUDI.<br \/>Genetic Testing and Molecular Biomarkers, 2013 Nov ; 17 (11) : 833 \u2013 9.<\/p>\n<p>87\/POTENTIAL ROLE OF TLR LIGAND IN AETHIOPATHOGENESIS OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.<br \/>O. ABIDA, D. BOUZID, S. KRICHEN-MAKNI, N. KHARRAT, A. MASMOUDI, M. ABDELMOULA, M. BEN AYED, H. TURKI, T. SELLAMI-BOUDAWARA, H. MASMOUDI.<br \/>Biochemistry &amp; Physiology, 2013, 2: 117.<\/p>\n<p>88\/ CONTRIBUTION OF PTPN22, CD28, CTLA-4 AND ZAP-70 VARIANTS TO THE RISK OF TYPE 1 DIABETES IN TUNISIANS.<br \/>F. ZOUIDI, M. STAYOUSSEF, D. BOUZID, H. FOURATI, O. ABIDA, M. BEN AYED, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H.<br \/>MASMOUDI.<br \/>Gene. 2014 Jan 1;533(1):420-6.<\/p>\n<p>89\/ ASSOCIATION OF BANK-1 AND CYTOKINE GENE POLYMORPHISMS WITH TYPE 1 DIABETES IN TUNISIA.<br \/>F. ZOUIDI, M. STAYOUSSEF, D. BOUZID, H. FOURATI, O. ABIDA, J. COSTA, M. BEN AYED, R. FAKHFAKH, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.<br \/>Gene. 2014 Feb 25;536(2):296-301.<\/p>\n<p>90\/ ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY AND RHEUMATOID FACTOR IN SOUTH TUNISIAN PATIENTS WITH RHEUMATOID ARTHRITIS: ASSOCIATION WITH DISEASE ACTIVITY AND severity.<br \/>MB. HAMAD, S. MARZOUK, N. KADDOUR, H. MASMOUDI, F. FAKHFAKH, A. REBAI, Z. BAHLOUL, A. MAALEJ.<br \/>Journal of Clinical Laboratory Analysis, 2014 Jan;28(1):21-6.<\/p>\n<p>91\/ EFFET D\u2019UN PROTOCOLE CYCLOPHOSPHAMIDE A INTERVALLE COURT AU COURS DE LA NEPHROPATHIE LUPIQUE.<br \/>H. FERIANI, I. AGREBI, K. KAMMOUN, M. KHARRAT, S. MAKNI, A. CHARFI, S. YAICH, F. JARRAYA, Y. CHAABOUNI, H. MASMOUDI, T.<br \/>BOUDAWARA, J. HACHICHA.<br \/>16\u00e8me R\u00e9union commune de la Soci\u00e9t\u00e9 de N\u00e9phrologie et de la Soci\u00e9t\u00e9 Francophone de dialyse. N\u00e9phrologie et Th\u00e9rapeutique. 2014 ; (10) : 331 \u2013 378.<\/p>\n<p>92\/ CAUSES AND OUTCOME OF HOSPITALISATIONS IN TUNISIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.<br \/>MOEZ JALLOULI , H. HRIZ , Y. CHERIF , S. MARZOUK , M. SNOUSSI,F. FRIKHA, R. BEN SALAH , H. MASMOUDI, Z. BAHLOUL .<br \/>Lupus Science &amp;Medicine, 2014 Jun 5; 1 (1).<\/p>\n<p>93\/ AUTOIMMUNE DISEASES ASSOCIATION STUDYWITH THE KIAA1109-IL2-IL21 REGION IN A TUNISIAN POPULATION.<br \/>D. BOUZID, H. FOURATI, A. AMOURI, I. MARQUES, O. ABIDA, N. TAHRI, C. PENHA-GONCALVES, H. MASMOUDI.<br \/>Molecular Biology Reports, 2014 Nov;41(11):7133-9.<\/p>\n<p>94\/ LATE-ONSET PRIMARY ANTIPHOSPHOLIPID SYNDOROME IN THE ELDERLY: A REPORT OF SEVEN CASES.<br \/>YOSRA CHERIF, M. JALLOULI, H. HRIZ, R. GOUIAA, S. MARZOUK, M. SNOUSSI, F. FRIKHA, H. MASMOUDI, Z. BAHLOUL.<br \/>Int. J. Rheum Dis, 2015 Jan ; 18 (1) : 103-7.<\/p>\n<p>95\/ NEONATAL LUPUS AND MATERNOFETAL TRANSMISSION OF ANTI-SSA\/RO AND ANTI-SSB\/LA ANTIBODIES.<\/p>\n<p>S. FEKI, A. TURKI, F. FRIKHA, H. HACHICHA, L. WALHA, A. GARGOURI, Z. BAHLOUL, H. MASMOUDI.<br \/>Archives de P\u00e9diatrie, 2015 Feb;22(2):154-9. French.<\/p>\n<p>96\/ ASSOCIATION OF TCR\/CD3, PTPN22, CD28 AND ZAP70 GENE POLYMORPHISMS WITH TYPE 1 DIABETES RISK IN TUNISIAN<br \/>POPULATION: FAMILY BASED ASSOCIATION STUDY\u201d<br \/>F. ZOUIDI, D. BOUZID, H. FOURATI, M. STAYOUSSEF, O. ABIDA, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.<br \/>Immunology Letters, 2015 Jan ; 163 (1) : 1 \u2013 7.<\/p>\n<p>97\/ LUPUS ERYTHEMATEUX SYSTEMIQUE A DEBUT PEDIATRIQUE : A PROPOS D\u2019UN CAS.<br \/>SANA KHLIF, H. HACHICHA, F. FRIKHA, S. FEKI, Z. BAHLOUL, H. MASMOUDI.<\/p>\n<p>PanAfrican Medical Journal, 2015 ; 20 ; 25.<\/p>\n<p>98\/ IS THERE ANY RELATIONSHIP BETWEEN POLYMORPHISM OF HEAT SHOCK PROTEIN 70 GENES AND PEMPHIGUS FOLIACEUS?<br \/>Amina TOUMI, O. ABIDA, M. BEN AYED, A. MASMOUDI, H. TURKI, H. MASMOUDI.<br \/>Immunology Letters, 2015 ; 164 : 94 \u2013 99.<\/p>\n<p>99\/ NOVEL AND RECURRENT AID MUTATIONS UNDERLIE PREVALENT AUTOSOMAL RECESSIVE FORM OF HIGM IN CONSANGUINEOUS<br \/>PATIENTS.<br \/>H. OUADANI, I. BEN-MUSTAPHA, M. BEN-ALI, L. BEN-KHEMIS, B. LARGU\u00c8CHE, R. BOUSSOFFARA, S. MAALEJ, I. FETNI, S. HASSAYOUN, A. MAHFOUDH, F. MELLOULI, S. YALAOUI, H. MASMOUDI, M. BEJAOUI, MR. BARBOUCHE.<br \/>Immunogenetics. 2016 Jan;68(1):19 \u2013 28. doi: 10.1007\/s00251-015-0878-6. Epub 2015 Nov 6.<\/p>\n<p>100\/ ELEVATED PROLACTIN LEVELS IN PATIENTS WITH PEMPHIGUS FOLIACEUS.<br \/>AMINA TOUMI, K. CHAABOUNI, O. ABIDA, H. HACHICHA, M. BEN AYED, A. MASMOUDI, H. TURKI, F. AYEDI, H. MASMOUDI.<br \/>Herald Scholary Open Access Journal of Clinical Dermatology and Therapy, 2016, 3: 017.<\/p>\n<p>101\/ ASSOCIATION BETWEEN THE IL2RA POLYMORPHISM AND TYPE 1 DIABETES RISK: FAMILY BASED ASSOCIATION STUDY.<br \/>Ferjeni ZOUIDI, D. BOUZID, H. FOURATI, R. FAKHFAKH, T. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.<br \/>Meta Gene, December 2016, 10 : 118 \u2013 122.<\/p>\n<p>102\/ AUTOANTIBODIES DIABETES AND MICRONUTRIMENTS IN TYPE 1 DIABETICS AND SIBLINGS OF ABIDJAN DISTRICT, IVORY COAST.<br \/>CHIAY\u00c9 CLAIRE ANTOINETTE YAPO-CREZOIT, A\u00cfSS\u00c9 FLORENCE JUDITH TR\u00c9BISSOU, FRANCIS ADOU YAPO, SANA KHLIF, AMINA LAHYANI, KOUMBA AGBO-SOUMAHORO, FATMA MAKNI AYEDI, HATEM MASMOUDI, JOSEPH ALLICO DJAMAN, MIREILLE DOSSO.<br \/>European Journal of Pharmaceutical and Medical Research, 2016,3(11), 637-643<\/p>\n<p>103\/ ACTIVATION INDUCED CYTIDINE DEAMINASE MUTANT (AID-HIS130PRO) FROM HYPER IGM 2 PATIENT RETAINED MUTAGENIC<\/p>\n<p>ACTIVITY ON SHM ARTIFICIAL SUBSTRATE.<br \/>Han\u00e8ne OUADANI, I. BEN-MUSTAPHA, M. BEN-ALI, B. LARGU\u00c8CHE, T. JOVANIC, S. GARCIA, B. ARCANGIOLI, H. ELLOUMI-ZGHAL, D. FATHALLAH, M. HACHICHA, H. MASMOUDI, F. ROUGEON, MR. BARBOUCHE.<br \/>Molecular immunology, Nov 2016, 4 ; 79 : 77 \u2013 82.<\/p>\n<p>104\/ CREM VARIANT RS17583959 CONFERRED SUSCEPTIBILITY TO T1D RISK IN THE TUNISIAN FAMILIES.<br \/>Ferjeni ZOUIDI, D. BOUZID, H. FOURATI, R. FAKHFAKH, Th. KAMMOUN, M. HACHICHA, C. PENHA-GONCALVES, H. MASMOUDI.<br \/>Immunology Letters, Jan. 2017 ;181:1-5.<\/p>\n<p>105\/ DIFFERENTIAL REACTIVE OXYGEN SPECIES PRODUCTION OF NEUTROPHILS AND THEIR OXIDATIVE DAMAGE IN PATIENTS WITH ACTIVE AND INACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS.<br \/>NesrineELLOUMI, RB. MANSOUR, S. MARZOUK, M. MSEDDI, R. FAKHFAKH, B. GARGOURI, H. MASMOUDI, S. LASSOUED.<br \/>Immunology Letters, Apr. 2017, 3 ; 184 : 1 \u2013 6.<\/p>\n<p>106\/ ROLE OF FOXP3 GENE POLYMORPHISM IN THE SUSCEPTIBILITY TO TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.<br \/>Mariem BEN JMAA, O. ABIDA, E. BAHLOUL, A. TOUMI, S. KHLIF, R. FAKHFAKH, N. ELLOUMI, K. SALLEMI, A. MASMOUDI, H. TURKI, H. MASMOUDI.<br \/>Immunology Letters, Apr. 2017, 16 ; 184 : 105 \u2013 111.<\/p>\n<p>107\/ THE INCREASED EXPRESSION OF TOLL-LIKE RECEPTOR 4 IN RENAL AND SKIN LESIONS IN LUPUS ERYTHEMATOSUS.<br \/>Nesrine ELLOUMI, R. FAKHFAKH, L. AYADI, K. SELLAMI, O. ABIDA, M. BEN JMAA, T. SELLAMI, K. KAMMOUN, H. MASMOUDI.<br \/>Journal of HistochemistryCytochemistry, Jul 2017 ; 65 (7) : 389 \u2013 398.<\/p>\n<p>108\/ GENETIC ASSOCIATION AND PHENOTYPIC CORRELATION OF TLR4 BUT NOT NOD2 VARIANTS WITH TUNISIAN INFLAMMATORY BOWEL DISEASE.<br \/>Sawsan FEKI, D. BOUZID, O. ABIDA, L. CHTOUROU, N. ELLOUMI, A. TOUMI, H. HACHICHA, A. AMOURI, N. TAHRI, H. MASMOUDI.<br \/>Journal of Digestive Diseases, Nov 2017 ; 18(11) : 625 \u2013 633.<\/p>\n<p>109\/ RELEVANT GENETIC POLYMORPHISMS AND KIDNEY EXPRESSION OF TOLL-LIKE RECEPTOR TLR5 AND TLR9 IN LUPUS NEPHRITIS.<br \/>NesrineELLOUMI, R. FAKHFAKH, O. ABIDA, L. AYADI, S. MARZOUK, H. HACHICHA, M. FOURATI, Z. BAHLOUL, MN. MHIRI, K. KAMMOUN, H. MASMOUDI.<br \/>Clinical &amp; Experimental Immunology, Dec 2017 ; 190(3) : 328 \u2013 339.<\/p>\n<p>110\/ POSITIVITE DES ANTICORPS ANTI-CYTOPLASME DES POLYNUCLEAIRES NEUTROPHILES CHEZ L\u2019ENFANT : PREVALENCE ET<br \/>ETIOLOGIES.<br \/>Am\u00e9ni JERBI, S. FEKI, S. BEN AMEUR, H. HACHICHA, L. GARGOURI, T. KAMOUN, A. MAHFOUDH, M. HACHICHA, H. MASMOUDI.<br \/>Annales de Biologie Clinique (Paris), Janv 2018 ; 76(1) : 68 \u2013 74.<\/p>\n<p>111\/ HUMAN LEUCOCYTE ANTIGENS-DRB1*03 IS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-SSB PRODUCTION IN<br \/>SOUTH TUNISIA.<br \/>Hend HACHICHA, A. KAMMOUN, N. MAHFOUDH, S. MARZOUK, S. FEKI, R. FAKHFAKH, H. FOURATI, S. HADDOUK, F. FRIKHA, L. GADDOUR, F. HAKIM, Z. BAHLOUL, H. MAKNI, H. MASMOUDI.<br \/>International Journal of Health Sciences, Vol. 12, Issue 1 (January \u2013 February 2018).<\/p>\n<p>112\/ HLA CLASS III: A SUSCEPTIBILITY REGION TO SYSTEMIC LUPUS ERYTHEMATOSUS IN TUNISIAN POPULATION.<br \/>Hend HACHICHA, N. MAHFOUDH, H. FOURATI, N. ELLOUMI, S. MARZOUK, S. FEKI, R. FAKHFAKH, F. FRIKHA, A. AYADI, A.MAATOUG, L. GADDOUR, F. HAKIM, Z. BAHLOUL, H. MAKNI, H. MASMOUDI, A. KAMMOUN<br \/>PLoS One. 2018 Jun 18 ; 13(6) : e0198549. doi: 10.1371\/journal.pone.0198549. eCollection 2018.<\/p>\n<p>113\/ INVOLVEMENT OF THE IL23\/TH17 PATHWAY IN THE PATHOGENESIS OF TUNISIAN PEMPHIGUS FOLIACEUS.<br \/>Mariem BEN JMAA, O. ABIDA, R. FAKHFAKH, E. BAHLOUL, Kh. SELLAMI, L. GADDOUR, N. ELLOUMI, M. BEN AYED, A. MASMOUDI, M. DHOUIB, M. ABDELMOULA, N. MAHFOUDH, H. MAKNI, H. TURKI, H. MASMOUDI<br \/>Mediators of Inflammation, 2018 Jul 12 ; 2018 : 8206983. Doi : 10.1155\/2018\/8206983. eCollection 2018.<\/p>\n<p>114\/ PROFIL EPIDEMIOLOGIQUE, CLINIQUE ET VALEUR DIAGNOSTIQUE DES ANTICORPS ANTI-JO1 (ANTICORPS ANTI-AMINOACYL-T-RNA-SYNTHETASES) ETUDE RETROSPECTIVE A PROPOS D\u2019UNE SERIE DE 22<\/p>\n<p>PATIENTS.<br \/>Faten FRIKHA, H. HACHICHA, I. JALLOULI, M. SNOUSSI, R. BEN SAAH, H. MASMOUDI, Z. BAHLOUL.<br \/>Revue M\u00e9dicale Internationale Maghr\u00e9bine, n\u00b0 251, Juillet-Ao\u00fbt 2018.<\/p>\n<p>115\/ THE INTRATHECAL POLYSPECIFIC ANTIVIRAL IMMUNE RESPONSE (MRZ REACTION): A POTENTIAL CEREBROSPINAL FLUID MARKER FOR MULTIPLE SCLEROSIS DIAGNOSIS.<\/p>\n<p>Sawsan FEKI, S. GARGOURI, S. MEJDOUB, M. DAMMAK, H. HACHICHA, O. HADIJI, L. FEKI, A. HAMMAMI, C. MHIRI, H. KARRAY, H. MASMOUDI.<br \/>Journal of Neuroimmunology, 2018 Aug 15 ; 321 : 66 \u2013 71.<\/p>\n<p>116\/ PEMPHIGUS HERPETIFORMIS IN SOUTH TUNISIA: A CLINICAL EXPRESSION OF PEMPHIGUS FOLIACEUS?<br \/>Am\u00e9ni JERBI, H. HACHICHA, S. FEKI, E. BAHLOUL, K. SELLAMI, O. ABIDA, S. CHARFI, A. BOUZID, T. SELLAMI BOUDAWARA, H. TURKI, A. MASMOUDI, H. MASMOUDI<br \/>International Journal of Dermatology. 2018 Sep ; 57 (9) : 1094 \u2013 1101. Doi: 10.1111\/ijd.14139.<\/p>\n<p>117\/ UPDATE ON IMMUNOGENETICS OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.<br \/>Hatem MASMOUDI, O. ABIDA, A. MASMOUDI, H. TURKI.<br \/>Journal of Leucocyte Biology. 2019 Feb; 105(2): 257 \u2013 265. doi: 10.1002\/JLB.MR0318-132R; Review.<\/p>\n<p>118\/ Progression of autoantibodies anti-GAD and anti-IA2 in type 1A Diabetics aged 5 to 21 years in C\u00f4te d\u2019ivoire.<br \/>A\u00efss\u00e9 F.J. TREBISSOU, P. SIBAILLY, A. ANKOTCHE, M. SANOGO, D. KOUASSI, M.Th. KOUASSI, H. MASMOUDI, A.F. YAPO.<br \/>Journal of Cellular Immunology, 2019, Volume 1, Issue 1.<\/p>\n<p>119\/ PERFORMANCES COMPARATIVES DES TESTS IMMUNOLOGIQUES DU LIQUIDE CEPHALO-RACHIDIEN DANS LE DIAGNOSTIC DE LA<br \/>SCLEROSE EN PLAQUES.<br \/>Sabrina MEJDOUB, S. FEKI, M. DAMMAK, N. FARHAT, H. HACHICHA, Ch. MHIRI, H. MASMOUDI.<br \/>Revue Francophone des Laboratoires, n\u00b0 514, Juillet-Ao\u00fbt 2019.<\/p>\n<p>120\/ CLINICAL AND SEROLOGICAL PROFILE OF SYSTEMIC SCLEROSIS IN TUNISIA: A RETROSPECTIVE OBERVATIONAL STUDY.<br \/>Raida BEN SALAH, F. FRIKHA, H. HACHICHA, I. CHABCHOUB, C. DAMMAK, M. SNOUSSI, M. JALLOULI, S. MARZOUK, H. MASMOUDI, Z. BAHLOUL.<br \/>La presse m\u00e9dicale, October 2019, Volume 48, Issue 10, e284-e291.<br \/>https:\/\/doi.org\/10.1016\/j.lpm.2019.07.037.<\/p>\n<p>121\/ SOUTH TUNISIAN PEMPHIGUS PATIENTS BEYOND 60 YEARS: EPIDEMIOLOGICAL PROFILE AND EVOLUTION.<br \/>Am\u00e9ni JERBI, H. HACHICHA, E. BAHLOUL, S. FEKI, K. SELLAMI, O. ABIDA, A. BOUZID, H. TURKI, A. MASMOUDI, H. MASMOUDI.<br \/>International Journal of Dermatology, November 2019, Volume 58, Issue11<br \/>e219-e220, doi : 10.1111\/ijd.14594.<\/p>\n<p>122\/ NEUROMYELITIS OPTICA SPECTRUM DISORDERS IN SOUTH OF TUNISIA: A RARE ENTITY WITH LOW SEROPREVALENCE OF ANTI- AQUAPORIN 4 AUTOANTIBODIES<\/p>\n<p>S. MEJDOUB, S. FEKI, M. DAMMAK, N. FARHAT , O. HDIJI, S. BOUKTHIR, H. HACHICHA, C. MHIRI, H. MASMOUDI.<br \/>Revue neurologique, 2020 May ; 176(4) : 261 \u2013 267. Doi : 10.1016\/j.neurol. 2019.<br \/>08.009. Epub 2019 Oct 24.<\/p>\n<p>123\/ INFECTION PAR LE NOUVEAU CORONAVIRUS : DU DEPISTAGE ET DIAGNOSTIC ANTIGENIQUES SEROLOGIQUES A L\u2019IMMUNITE ET LA REINFECTION.<br \/>Hatem MASMOUDI.<br \/>Revue Tunisienne de Biologie Clinique, Juin 2020 ; n\u00b02 Sp\u00e9cial Covid-19 ; 6-26 ; Review.<\/p>\n<p>124\/ CHROMOSOME 2Q33 GENETIC POLYMORPHISMS IN TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS\u201d<br \/>Olfa ABIDA, E. BAHLOUL, M. BEN JMAA, Kh. SELLAMI, F. ZOUIDI, R. FAKHFAKH, N. MAHFOUDH, H. TURKI, H. MASMOUDI.<br \/>Molecular Genetics and Genomic Medicine, 2020; 00: e1476.<br \/>https:\/\/doi.org\/10.1002\/mgg3.1476.<\/p>\n<p>125\/ DAPSONE IN THE TREATMENT OF PEMPHIGUS FOLIACEUS: A CLINICAL SERIES OF 23 CASES AND A LITERATURE REVIEW.<br \/>Bahloul E, Hammami F, Jerbi A, Abida O, Sellami K, Hachicha H, Amouri M, Boudaya S, Mseddi M, Masmoudi H, Masmoudi A, Turki H.<br \/>Ann Dermatol Venereol. 2020 Dec ;147(12) :873-876.<br \/>Doi : 10.1016\/j.annder.2020.07.007. Epub 2020 Aug 18. PMID : 32826082<\/p>\n<p>126\/ TOLL-LIKE-RECEPTOR GENE POLYMORPHISMS IN TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.<br \/>Abida O, Bahloul E, Elloumi N, Toumi A, Tahri S, Ben Jmaa M, Fakhfakh R, Mahfoudh N, Turki H, Masmoudi H.<br \/>Biomed Res Int. 2020 Nov 5;2020:6541761. doi: 10.1155\/2020\/6541761.<br \/>eCollection 2020. PMID : 33204706<\/p>\n<p>127\/ MELATONIN INGESTION BEFORE INTRADIALYTIC EXERCISE IMPROVES IMMUNE RESPONSES IN HEMODIALYSIS PATIENTS.<br \/>Marzougui H, Hammouda O, Ben Dhia I, Maaloul R, Agrebi I, Chaker H, Kammoun K, Ben Hmida M, Ayadi F, Kallel C, Driss T, Turki M, Masmoudi H, Hachicha H.<br \/>Int Urol Nephrol. 2021 Mar;53(3):553-562. Doi : 10.1007\/s11255-020-02643-3.<br \/>Epub 2020 Sep 23.PMID: 32965623<\/p>\n<p>128\/ AUTOANTIBODIES AGAINST DESMOGLEIN 1 AND 3 IN SOUTH TUNISIAN PEMPHIGUS.<\/p>\n<p>Jerbi A, Hachicha H, Feki S, Abida O, Bahloul E, Sellami K, Bouzid A, Turki H, Masmoudi A, Masmoudi H.<br \/>Tunis Med. 2021 Octobre;99(10):992999. PMID: 35288901<\/p>\n<p>129\/ RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features.<br \/>Elloumi N, Fakhfakh R, Abida O, Hachicha H, Marzouk S, Fourati M, Bahloul Z, Masmoudi H.<br \/>Int J Immunogenet. 2021 Jun;48(3):250-259. doi: 10.1111\/iji.12531. Epub 2021 Mar 1. PMID: 33650302<\/p>\n<p>130\/ Vitamin D status and CYP27B1-1260 promoter polymorphism in Tunisian patients with systemic lupus erythematosus.<br \/>Fakhfakh R, Feki S, Elleuch A, Neifar M, Marzouk S, Elloumi N, Hachicha H, Abida O, Bahloul Z, Ayadi F, Masmoudi H.<br \/>Mol Genet Genomic Med. 2021 Mar;9(3): e1618. doi: 10.1002\/mgg3.1618.<br \/>Epub 2021 Feb 17. PMID: 33594806 Free PMC article.<\/p>\n<p>131\/ Antinuclear antibodies in children: clinical signification and diagnosis utility.<br \/>Mejdoub S, Hachicha H, Gargouri L, Feki S, Mahfoudh A, Masmoudi H.<br \/>Tunis Med. 2021 Octobre; 99(10):980-984.PMID: 35288899<\/p>\n<p>132\/ ANNEXIN A1 AND ITS RECEPTOR GENE POLYMORPHISMS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE TUNISIAN POPULATION.<br \/>F. Dhaffouli, H. Hachicha, O. Abida, N. Gharbi, N. Elloumi, H. Kanoun, N. Belguith, S. Marzouk, R. Fakhfakh, S. Feki, H. Mnif, H. Kamoun, Z. Bahloul, H. Masmoudi.<br \/>Clinical Rheumatology, Jan 2022. doi.org\/10.1007\/s10067-022-06057-7.<\/p>\n<p>133\/ ASSOCIATION OF IGHM POLYMORPHISMS WITH SUSCEPTIBILITY TO TYPE 1 DIABETES.<br \/>Ferjeni Zouidi, Raouia Fakhfakh, Olfa Abida, Carlos Penha\u2010Goncalves, Hatem Masmoudi.<br \/>Immunol Res. 2022 Jun ; 70(3) : 325-330. Doi : 10.1007\/s12026-021-09252-x. Epub 2022 Jan 20. PMID : 35048256.<\/p>\n<p>134\/ TH17 AND TH1 CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH FOCUS ON LUPUS NEPHRITIS.<br \/>Fakhfakh R, Zian Z, Elloumi N, Abida O, Bouallegui E, Houssaini H, Volpe E, Capone A, Hachicha H, Marzouk S, Bahloul Z, Masmoudi H.<br \/>Immunol Res. 2022 Jun 6. doi: 10.1007\/s12026-022-09296-7. Online ahead of print.<br \/>PMID: 35666434.<\/p>\n<p>135\/ ANTINUCLEAR ANTIBODIES POSITIVITY IS NOT RARE DURING MULTIPLE SCLEROSIS AND IS ASSOCIATED WITH RELAPSING STATUS AND IGG OLIGOCLONAL BANDS POSITIVITY<\/p>\n<p>Sabrina Mejdoub, Sawsan Feki, Nouha Farhat, Mariem Dammak, Hend Hachicha, Salma Sakka, Abir Ayedi, Faten Ayedi, Chokri Mhiri, Hatem Masmoudi<br \/>Revue neurologique (2022), https:\/\/doi.org\/10.1016\/j.neurol.2021.11.016.<\/p>\n<p>136\/ AUTOANTIBODIES TO ZINC TRANSPORTER 8 AND SLC30A8 GENOTYPE IN TYPE 1 DIABETES CHILDHOOD : A PIONEERING STUDY IN NORTH AFRICA.<br \/>Fakhfakh R, Kmiha S, Tahri S, Feki S, Zouidi F, Abida O, Hachicha M, Kammoun T, Masmoudi H.<br \/>J Diabetes Res. 2022 May 23;2022: 2539871. doi: 10.1155\/2022\/2539871. eCollection 2022.PMID: 3565636.<\/p>\n<p>137\/ ROLE OF INNATE IMMUNE RECEPTORS TLR 4 AND 2 POLYMORPHISMS IN SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY<br \/>N. Elloumi, S. Tahri, R. Fakhfakh, O. Abida, N. Mahfoudh, H. Hachicha, S. Marzouk, Z. bahloul, H. Masmoudi<br \/>Ann Hum Genet. 2022 May; 86(3):137-144. Doi : 10.1111\/ahg.12458. Epub 2022<br \/>Feb 7. PMID : 35128637.<\/p>\n<p>138\/ PEMPHIGUS HERPETIFORMIS IN A 4-YEAR-OLD CHILD: CASE REPORT AND REVIEW OF THE LITERATURE<br \/>F. Hayder, E. Bahloul, K. Sellami, A. Jerbi, H. Masmoudi, M. Zghal, L. Ayedi, A. Aounallah, H. Turki.<br \/>Clin Case Rep. 2022; 10:e05567. doi:10.1002\/ccr3.5567.<\/p>\n<p>139\/ EVALUATION OF X CHROMOSOME INACTIVATION IN ENDEMIC TUNISIAN PEMPHIGUS FOLIACEUS.<br \/>ABIDA O, Elloumi N, Bahloul E, Hachicha H, Sellami Kh, Fakhfakh R, Marzouk S, Ben Ayed I, Mahfoudh N, Turki H, Masmoudi H.<br \/>Molecular Genetics and Genomic Medicine. 09 November 2022.<br \/>doi.org\/10.1002\/mgg3.2080. doi: 10.1002\/mgg3.2080. Epub 2022 Nov 9.<br \/>PMID: 36349750.<\/p>\n<p>140\/ ROLE OF INNATE IMMUNE RECEPTORS TLR 4 AND 2 POLYMORPHISMS IN SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY<br \/>Elloumi N, Safa Tahri, Raouia Fakhfakh, Olfa Abida, Nadia Mahfoudh, Hend Hachicha, Sameh Marzouk, Zouhir Bahloul, Hatem Masmoudi<br \/>Ann Hum Genet. 2022 May;86(3):137-144. doi: 10.1111\/ahg.12458. Epub 2022 Feb<br \/>7. PMID: 35128637<\/p>\n<p>141\/ TH17 AND TH1 CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH FOCUS ON LUPUS NEPHRITIS.<br \/>Fakhfakh R, Zian Z, Elloumi N, Abida O, Bouallegui E, Houssaini H, Volpe E,<br \/>Capone A, Hachicha H, Marzouk S, Bahloul Z, Masmoudi H.<br \/>Immunol Res. 2022 Jun 6. doi: 10.1007\/s12026-022-09296-7. Online ahead of print.<br \/>PMID: 35666434<\/p>\n<p>142\/ ANTI-MITOCHONDRIAL ANTIBODIES DETECTION ASSAYS FOR DIAGNOSIS OF PRIMARY BILIARY CHOLANGITIS IN SOUTHERN<br \/>TUNISIA POPULATION<br \/>S. Mejdoub, Z. Hamza, H. Hachicha, L. Chtourou, S. Marrzouk, S. Feki, A. Jerbi, S. Boukthir, Z. Bahloul, N. Tahri, H. Masmoudi.<br \/>Ann Biol Clin (Paris). 2022 Sep 1 ; 80(5) :423-429. doi:10.1684\/abc.2022.1761.PMID: 36453746<\/p>\n<p>143\/ INTRATHECAL B CELL-RELATED MARKERS FOR AN OPTIMIZED BIOLOGICAL INVESTIGATION OF MULTIPLE SCLEROSIS PATIENTS<br \/>Sawsan Feki, Mariem Damak, Salma Sakka, Yesmine Ben Ali, Sabrina Mejdoub, Nadia Bouattour, Hend Hachicha, Chokri Mhiri, Hatem Masmoudi.<br \/>www.nature.com\/scientificreports Scientific Reports | (2022) 12 :16425 |<span>\u00a0<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-022-19811-3\">https:\/\/doi.org\/10.1038\/s41598-022-19811-3<\/a><span>\u00a0<\/span>144\/ DIFFERENTIAL EXPRESSION OF ANTI-INFLAMMATORY RNA BINDING PROTEINS IN LUPUS NEPHRITIS.<br \/>Fakhfakh R, Bouallegui E, Houssaini H, Elloumi N, Dhafouli F, Abida O, Hachicha H, Marzouk S, Bahloul Z, Kammoun K, Boudawara T, Masmoudi H. Life (Basel).<br \/>2022 Sep 23 ;12(10) :1474. Doi :10.3390\/life12101474.<br \/>PMID : 36294909<\/p>\n<p>145\/ EPIDEMIOLOGICAL STUDY ON THE EVALUATION OF MOLECULAR AND IMMUNOLOGICAL ASSAY FOR THE DETECTION OF TOXOPLASMA GONDII IN WOMEN\u2019S ABORTION.<br \/>Alkardhi IKA, Masmoudi H, Muhammedand HA, Sellami H.<br \/>Cell Mol Biol (Noisy-le-grand). 2022 Apr 30 ; 68(4) :122-128.<br \/>Doi : 10.14715\/cmb\/2022.68.4.15.PMID : 35988283<\/p>\n<p>146\/ BICLONAL GAMMOPATHIES IN SOUTH TUNISIA: CLINICAL AND<br \/>BIOLOGICAL CHARACTERISTICS.<br \/>Jerbi A, Hachicha H, Charfi A, Kallel F, Feki S, Ben Ayed M, Ayadi F, Akrout R,<br \/>Frikha F, Amouri A, Kammoun K, Mdhaffar M, Ben Hmida M, Tahri N, Bahloul Z,<br \/>Baklouti S, Elloumi M, Masmoudi H.<br \/>Lab Med. 2023 Sep 5;54(5):464-468. doi: 10.1093\/labmed\/lmac153.<br \/>PMID: 36799924<\/p>\n<p>147\/ COWS\u2019 MILK ALTERNATIVES FOR CHILDREN WITH COWS\u2019 MILK<br \/>PROTEIN ALLERGY \u2013 REVIEW OF HEALTH BENEFITS AND RISKS OF<br \/>ALLERGIC REACTION<br \/>Roua Lajnaf, Sawsan Feki, Salma Ben Ameur, Hamadi Attia, Thouraya Kammoun,<br \/>Mohamed Ali Ayadi, Hatem Masmoudi<br \/>International Dairy Journal, 24 February 2023, 105624;<br \/>https:\/\/doi.org\/10.1016\/j.idairyj.2023.105624<br \/>148\/ THE PRESENCE OF TWO LIGHT CHAIN BANDS ON<br \/>IMMUNOFIXATION IS ASSOCIATED WITH POOR OUTCOMES IN NEWLY<br \/>DIAGNOSED MULTIPLE MYELOMA PATIENTS.<br \/>Jerbi A, Turki O, Hachicha H, Kallel Sarbeji F, Feki S, Mejdoub S, Kammoun K,<br \/>Ben Hmida M, Elloumi M, Masmoudi H.<br \/>Ann Hematol. 2023 Jun;102(6):1459-1466. doi: 10.1007\/s00277-023-05221-6.<br \/>Epub 2023 Apr 15. PMID: 37060464<br \/>149\/ CHARACTERISTICS OF ADULT-ONSET AUTO-IMMUNE TYPE 1<br \/>DIABETES.<br \/>Kacem FH, Jerbi A, Allymamod BT, Abed WB, Mnif M, Charfi N, Elleuch M,<br \/>Rekik N, Masmoudi H, Abid M.<br \/>Am J Med Sci. 2023Jul; 366(1):49-56. doi: 10.1016\/j.amjms.2023.04.009. Epub<br \/>2023 Apr 22.PMID: 37088301<br \/>150\/ miRNA IMPLICATION IN THE PATHOGENESIS AND THE OUTCOME<br \/>OF TUNISIAN ENDEMIC PEMPHIGUS FOLIACEUS.<br \/>Khabou B, Fakhfakh R, Tahri S, Bahloul E, Hadj Kacem H, Belmabrouk S,<br \/>Hachicha H, Sellami K, Turki H, Masmoudi H, Abida O.<br \/>Exp Dermatol. 2023 Jul;32(7):1132-1142. doi: 10.1111\/exd.14821. Epub 2023 Apr<br \/>28.PMID: 37114366<br \/>151\/ GENES REGULATING OXIDATIVE-INFLAMMATORY RESPONSE IN<br \/>CIRCULATING MONOCYTES AND NEUTROPHILS IN SEPTIC SYNDROME<br \/>Elloumi N, Bahloul M, Benabdallah E, Kharrat S, Fakhfakh R, Bouchaala K, Abida<br \/>O, Chtara K, Masmoudi H, Bouaziz M.<br \/>Biol Futur. 2023 Jun;74(1-2):199-207. doi: 10.1007\/s42977-023-00168-1. Epub<br \/>2023 Jun 8.PMID: 37291472<\/p>\n<p>152\/ HUMAN EPIDERMAL KERATINOCYTES AND HUMAN DERMAL<br \/>FIBROBLASTS INTERACTIONS SEEDED ON GELATIN HYDROGEL FOR<br \/>FUTURE APPLICATION IN SKIN IN VITRO 3-DIMENSIONAL MODEL<br \/>Tahri Safa, Maarof M, Masri S, Che Man R, Masmoudi H, Fauzi MB.<br \/>Front Bioeng Biotechnol. 2023 Jun 23;11:1200618. doi: 10.3389\/fbioe. 2023.<br \/>1200618. eCollection 2023.PMID: 37425369<br \/>153\/ ICOS GENE POLYMORPHISMS IN SYSTEMIC LUPUS<br \/>ERYTHEMATOSUS: A CASE-CONTROL STUDY<br \/>Hana Houssaini, Emna Bouallegui, Olfa Abida, Safa Tahri, Nesrine Elloumi, Hend<br \/>Hachicha, Sameh Marzouk, Zouhir Bahloul, Masmoudi Hatem, Raouia Fakhfakh<br \/>Int J Immunogenet. 2023 Aug;50(4):194-205. doi: 10.1111\/iji.12625. Epub 2023<br \/>Jun 20.PMID: 37338463<br \/>154\/ RECENT ADVANCES IN SELECTIVE ALLERGIES TO MAMMALIAN<br \/>MILK PROTEINS NOT ASSOCIATED WITH COW\u2019S MILK PROTEINS<br \/>ALLERGY.<br \/>Lajnaf R, Feki S, Ben Ameur S, Attia H, Kammoun T, Ayadi MA, Masmoudi H.<br \/>Food Chem Toxicol. 2023 Aug;178:113929. doi: 10.1016\/j.fct.2023.113929. Epub<br \/>2023 Jul 3.PMID: 37406758 Review.<br \/>155\/ VITAMIN D DEFICIENCY IN RELATION WITH THE SYSTEMIC AND<br \/>CENTRAL INFLAMMATION DURING MULTIPLE SCLEROSIS.<br \/>Feki S, Naifar M, Dammak M, Majdoub S, Sakka S, Ben AY, Hachicha H, Mhiri<br \/>C, Ayadi F, Masmoudi H.<br \/>J Med Biochem. 2023 Aug 25;42(3):364-375. doi: 10.5937\/jomb0-37676.<br \/>PMID: 37814621<br \/>156\/ TUBULAR EXPRESSION OF TOLL-LIKE RECEPTOR 9 IN LUPUS AND<br \/>PRIMARY MEMBRANOUS NEPHROPATHY.<br \/>Elloumi N, Fakhfakh R, Masmoudi H, Kammoun K.<br \/>Tunis Med. 2024 Apr 5 ;102(4) :241-244. doi :<br \/>10.62438\/tunismed.v102i4.4273.PMID: 38746965<br \/>157\/ DIRECT MEDICAL COST RELATED TO THE MANAGEMENT OF<br \/>PEMPHIGUS: A PILOT TUNISIAN STUDY.<br \/>Hayder F, Bahloul E, Yaich S, Turki S, Sellami K, Litaiem N, Masmoudi H, Turki<br \/>M, Turki H.<br \/>Tunis Med. 2024 Feb 5;102(2):74-77. doi:<br \/>10.62438\/tunismed.v102i2.4651.PMID: 38567471<br \/>158\/ UNRAVELING THE ROLE OF THE VITAMIN D-VDR PATHWAY IN<br \/>PEMPHIGUS VULGARIS FROM TUNISIAN PATIENTS.<\/p>\n<p>DHAFFOULI F, ELLOUMI N, TAHRI S, SELLAMI K, MSEDDI M, FRIKHA<br \/>R, BAHLOUL E, CHARFI A, TURKI H, HACHICHA H, MASMOUDI H,<br \/>ABIDA O.STEROIDS. 2024 SEP;209:109454. DOI:<br \/>10.1016\/J.STEROIDS.2024.109454. EPUB 2024 JUN 13.PMID: 38878876<br \/>159\/ EXPLORING THE ROLE OF VITAMIN D-VDR PATHWAY IN<br \/>PEMPHIGUS FOLIACEOUS: A NOVEL PERSPECTIVE ON DISEASE<br \/>PATHOGENESIS.<br \/>TAHRI S, ELLOUMI N, KHABOU B, FRIKHA R, TURKI H, MAHFOUDH N,<br \/>BAHLOUL E, HACHICHA H, MASMOUDI H, ABIDA O.<br \/>ARCH DERMATOL RES. 2024 JUL 3;316(7):449. DOI: 10.1007\/S00403-024-<br \/>03192-W.PMID: 38958777<br \/>160\/ Infrequent patterns in cerebrospinal fluid isofocusing test: Clinical significance<br \/>and contribution of IgG index and Reiber diagram to their interpretation.<br \/>Maaloul M, Mejdoub S, Sakka S, Hachicha H, Dammak M, Koubaa F, Mhiri<br \/>C, Masmoudi H, Feki S.<br \/>Mult Scler Relat Disord. 2024 Apr;84:105509. doi: 10.1016\/j.msard.2024.105509.<br \/>Epub 2024 Feb 18.PMID: 38422634<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb1280px\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][et_pb_divider color=\u00a0\u00bbrgba(0,0,0,0.12)\u00a0\u00bb divider_position=\u00a0\u00bbcenter\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb theme_builder_area=\u00a0\u00bbpost_content\u00a0\u00bb][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1\/ Analysis of the cellular origin of T15 idiotype.P.A CAZENAVE, H. MASMOUDI, T. MOTA-SANTOS, A. COUTINHO.In : Idiotypic networks in Biology and Medicine.Elsevier Science Publishers, Amsterdam, 1990, 65 \u2013 68. 2\/ Immunologie fondamentale et immunopathologie \u00e0 l\u2019usage des \u00e9tudiants en M\u00e9decine, Biologie et Pharmacie \uf0b2.Hatem MASMOUDI et Amel EL GAAIED BEN AMMAR.Centre de Publications Universitaire [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-79","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/pages\/79","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/comments?post=79"}],"version-history":[{"count":4,"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/pages\/79\/revisions"}],"predecessor-version":[{"id":145,"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/pages\/79\/revisions\/145"}],"wp:attachment":[{"href":"https:\/\/drhatemmasmoudi.com\/index.php\/wp-json\/wp\/v2\/media?parent=79"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}